These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1032 related items for PubMed ID: 28841223

  • 1. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
    Tran Cao HS, Zhang Q, Sada YH, Chai C, Curley SA, Massarweh NN.
    Cancer; 2018 Jan 01; 124(1):74-83. PubMed ID: 28841223
    [Abstract] [Full Text] [Related]

  • 2. Outcome of adjuvant therapy in biliary tract cancers.
    McNamara MG, Walter T, Horgan AM, Amir E, Cleary S, McKeever EL, Min T, Wallace E, Hedley D, Krzyzanowska M, Moore M, Gallinger S, Greig P, Serra S, Dawson LA, Knox JJ.
    Am J Clin Oncol; 2015 Aug 01; 38(4):382-7. PubMed ID: 24572429
    [Abstract] [Full Text] [Related]

  • 3. Systemic adjuvant chemotherapy for cholangiocarcinoma surgery: A systematic review and meta-analysis.
    Rangarajan K, Simmons G, Manas D, Malik H, Hamady ZZ.
    Eur J Surg Oncol; 2020 Apr 01; 46(4 Pt A):684-693. PubMed ID: 31761507
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma.
    Kim YS, Hwang IG, Park SE, Go SI, Kang JH, Park I, Oh SY, Ji JH, Song HN, Park SH, Kim ST, Park JO.
    Cancer Chemother Pharmacol; 2016 May 01; 77(5):979-85. PubMed ID: 27017615
    [Abstract] [Full Text] [Related]

  • 6. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T, Qin LX, Zhou J, Sun HC, Qiu SJ, Ye QH, Wang L, Tang ZY, Fan J.
    Liver Int; 2014 Jul 01; 34(6):953-60. PubMed ID: 24134199
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Association of Liver-Directed Local Therapy With Overall Survival in Adults With Metastatic Intrahepatic Cholangiocarcinoma.
    Sebastian NT, Tan Y, Miller ED, Williams TM, Noonan AM, Hays JL, Abdel-Misih S, Diaz DA.
    JAMA Netw Open; 2019 Sep 04; 2(9):e1911154. PubMed ID: 31517963
    [Abstract] [Full Text] [Related]

  • 9. Adjuvant Chemotherapy and Radiation Therapy is Associated with Improved Survival for Patients with Extrahepatic Cholangiocarcinoma.
    Hoehn RS, Wima K, Ertel AE, Meier A, Ahmad SA, Shah SA, Abbott DE.
    Ann Surg Oncol; 2015 Dec 04; 22 Suppl 3():S1133-9. PubMed ID: 25976862
    [Abstract] [Full Text] [Related]

  • 10. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
    Zeng ZC, Tang ZY, Fan J, Zhou J, Qin LX, Ye SL, Sun HC, Wang BL, Li D, Wang JH, Zeng MS, Guo W, Tan YS.
    Cancer J; 2006 Dec 04; 12(2):113-22. PubMed ID: 16630402
    [Abstract] [Full Text] [Related]

  • 11. Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma--a single-center experience.
    Scheuermann U, Kaths JM, Heise M, Pitton MB, Weinmann A, Hoppe-Lotichius M, Otto G.
    Eur J Surg Oncol; 2013 Jun 04; 39(6):593-600. PubMed ID: 23611755
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Failure to administer multimodality therapy leads to sub-optimal outcomes for patients with node-positive biliary tract cancers in the United States.
    Sheka AC, Altman A, Marmor S, Hui JYC, Denbo JW, Ankeny JS, Jensen EH.
    Surg Oncol; 2020 Sep 04; 34():298-303. PubMed ID: 32891346
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809).
    Gholami S, Colby S, Horowitz DP, Guthrie KA, Ben-Josef E, El-Khoueiry AB, Blanke CD, Philip PA, Kachnic LA, Ahmad SA, Rocha FG.
    Ann Surg Oncol; 2023 Mar 04; 30(3):1354-1363. PubMed ID: 36622529
    [Abstract] [Full Text] [Related]

  • 19. Estimating survival benefit of adjuvant therapy based on a Bayesian network prediction model in curatively resected advanced gallbladder adenocarcinoma.
    Geng ZM, Cai ZQ, Zhang Z, Tang ZH, Xue F, Chen C, Zhang D, Li Q, Zhang R, Li WZ, Wang L, Si SB.
    World J Gastroenterol; 2019 Oct 07; 25(37):5655-5666. PubMed ID: 31602165
    [Abstract] [Full Text] [Related]

  • 20. Survival benefit with adjuvant radiotherapy after resection of distal cholangiocarcinoma: A propensity-matched National Cancer Database analysis.
    Kamarajah SK, Bednar F, Cho CS, Nathan H.
    Cancer; 2021 Apr 15; 127(8):1266-1274. PubMed ID: 33320344
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 52.